The Federal program to combat cardiovascular diseases

Тип статьи:
Авторская
The Federal program to combat cardiovascular diseases


Madalas nagtatanong ang mga tao sa mga botika tungkol sa mga gamot laban sa presyon ng bagong henerasyon na walang side effects. Pero sa totoong buhay, hindi ito nangyayari. Lahat ng epektibong gamot ay may kanya-kanyang side effects. Kailangan mong maglaan ng maraming oras kasama ang iyong doktor para piliin ang tamang grupo ng gamot laban sa high blood pressure para sa'yo.

ЧИТАТЬ ДАЛЕЕ ...







































The Federal program to combat cardiovascular diseases

Оглавление



Описание The Federal program to combat cardiovascular diseases

The Federal program to combat cardiovascular diseasesCardio Balance is formulated and made after years of rigorous research and clinical study of the ingredients. The unique combination of each ingredient brings out optimal effectiveness in supporting heart and blood pressure. Cardio Balance is formulated and made after years of rigorous research and clinical study of the ingredients. The unique combination of each ingredient brings out optimal effectiveness in supporting heart and blood pressure.

The Federal program for the control of cardiovascular diseases: strategies and prospects for successCardiovascular disease (CVD) is in Germany, one of the main causes of morbidity and mortality. According to statistics from the Robert Koch Institute, they cause almost a third of all death — a fact that makes the introduction of comprehensive prevention measures urgently needed. In this connection was initiated at the Federal level, a nationwide program to combat cardiovascular diseases, which includes several strategic pillars.Objectives of the programmeSit the program's core goals:Reduction in the incidence of heart attacks and strokes by at least 20% within ten years;Improving the early diagnosis of risk factors such as hypertension, hyperlipidemia, and Diabetes mellitus;Increase in population education about healthy lifestyle (diet, physical activity, not Smoking);The strengthening of the cooperation between General practitioners, specialist physicians, and prevention facilities.Measures and implementationThe program relies on a combination of primary, secondary and tertiary prevention:Primary prevention:Establishment of nationwide health campaigns to raise awareness of risk factors;Introduction of free health screening for people aged 40 and over;Support of local sports and exercise programs.Secondary prevention:Standardization of aftercare concepts to heart attack or stroke;Training of patients in cardiovascular self‑management programs;Improved medication management and Compliance support.Tertiary prevention:Expansion of rehabilitation services with a focus on cardiovascular;Interdisciplinary care of high-risk patients by the heart team;Research funding for the development of innovative treatment strategies.Evaluation and resultsFirst evaluation reports after five years of duration of the program show positive Trends:a reduction in the average blood pressure values in the population by 5-7 mmHg;an increase in participation in screening from 45% to 68%;a decrease in hospitalizations due to acute cardiovascular events by 15%.Nevertheless, challenges remain, particularly in the integration of socially disadvantaged groups, and the long-term change of life styles.ConclusionThe Federal program for the control of cardiovascular diseases has proved to be an effective Instrument for the reduction of morbidity and mortality. Through the consistent continuation and adaptation to current health challenges and be a positive influence on public health can be further expanded.





Зачем нужен The Federal program to combat cardiovascular diseases

Constant high levels of stress can disturb the blood flow and blood pressure and can damage vessels, and you may experience dizziness, extreme fatigue, or body aches with no wish to get out of bed. This stress-induced fatigue can make your blood pressure high and needs to be monitored. The health of hypertension men's watch Online Diagnostics Of Cardiovascular Diseases

The health of hypertension men's watch Online

Diagnostics Of Cardiovascular Diseases

Regurgitation with cardiovascular diseases

Regurgitation with cardiovascular diseases




Мнение эксперта

Ang arteryal na hypertension o hypertension ay isang kondisyon ng patuloy na systolic at diastolic na presyon ng dugo, kung saan ang mga sukatan ay lumalagpas sa 140/90 mmHg. Ang mataas na presyon ay nagpapakita ng mga hindi komportableng sintomas. Отзывы о The Federal program to combat cardiovascular diseases

Ольга:




Как заказать?

Заполните форму для консультации и заказа The Federal program to combat cardiovascular diseases. Оператор уточнит у вас все детали и мы отправим ваш заказ. Через 3-7 дней вы получите посылку и оплатите её при получении.

Cardio Balance against high blood pressure. Year of the fight against cardiovascular diseases. Hawthorn for high blood pressure. Cervical gymnastics for high blood pressure. Ektrak mula sa prutas ng cranberry Ektrak mula sa prutas ng appleberry Magnesium L-Arginin Ektrak mula sa dahon at bulaklak ng hawthorn Pulbos ng bulaklak ng hibiscus Ektrak mula sa dahon ng oliba Ektrak mula sa buto ng ubas Ektrak mula sa black currant Coenzyme Q10 Bitamina B6 Folate

Ginagamit ito bilang biologically active na pampadagdag sa pagkain — dagdag na pinagmumulan ng mga bitamina — B2, B6, C, mga organikong asido — mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6.

Risk factors for cardiovascular disease table

xn--24-vlchlkv.xn--p1ai/articles/3195-diet-cardiovascular-disease.html

silvernz.beget.tech/articles/44527-anemia-cardiovascular-disease.html


Google
Google


The best remedy for high blood pressure is the newest Generation ofHigh blood pressure (arterial hypertension) is one of the most common cardiovascular disease and a major risk factor for heart attacks, strokes and kidney disease. Advances in pharmacology have led in recent years to new therapeutic options, particularly to drugs of the latest Generation, which have a higher efficacy and better tolerability.Novel Mechanisms Of ActionOne of the most important breakthroughs relates to the development of Angiotensin Receptor‑Neprilysin inhibitors (ARNIs). These combination products combine two modes of action:Inhibition of the Angiotensin‑II‑receptor (similar to ARBs — Angiotensin II receptor blockers),Inhibition of Neprilysin, an enzyme that natural blood reduces pressure lowering peptides (such as natriuretic peptides).A well-known representative of this class of Sacubitril/Valsartan, which demonstrated in clinical studies, a significant reduction in cardiovascular risk compared to conventional therapies.Other innovative approachesIn addition to ARNIs, the following novel strategies are being explored, and they are already used clinically:Endothelin‑receptor antagonists act on the vascular regulation and are mainly used for special forms of hypertension (for example, in the case of chronic renal insufficiency).CNS‑targeted drugs with selective effects modulate the Central blood pressure regulation in the absence of strong sedative side effects.Genbasiertes RNA interference therapeutic agent (e.g., Inclisiran) — lowers LDL‑cholesterol levels and, indirectly, the blood pressure by long-term Regulation of lipid metabolism genes.Clinical evidence and benefitsStudies such as the PARADIGM‑HF and PROVE showed HF:around 20% lower Rate of cardiovascular deaths and hospitalizations with the use of Sacubitril/Valsartan compared to Enalapril,significant improvement in left ventricular function,a favorable side effect profile (comparable with standard therapies).Practical aspects of the applicationThe new Generation of blood-pressure-lowering drugs offers the following advantages:reduced dose adjustment frequency (long-acting formulations),combined mechanisms of action (less separate preparations),better patient compliance due to easier administration schedules,individual adaptation to co-morbidities (Diabetes, kidney disease, congestive heart failure).ConclusionDrugs of the latest Generation, particularly ARNIs — represent a significant advance in the treatment of high blood pressure. You connect a high efficacy with an improved safety and open up new perspectives for patients with high cardiovascular risk. Nevertheless, the individual Benefit-risk assessment, as well as the close medical Monitoring during therapy is essential.Would you like me to make a certain section in more detail, or more technical information to add?
Нет комментариев. Ваш будет первым!
Используя этот сайт, вы соглашаетесь с тем, что мы используем файлы cookie.